Routine Breast Cancer Screening Makes Mark In U.K. Panel Review
This article was originally published in The Gray Sheet
Executive Summary
Based on an analysis of 11 randomized trials, a government-commissioned panel in the U.K. calculated a 20% relative risk reduction in breast cancer death among women who were invited for routine mammography screening.
You may also be interested in...
Federal Task Force Plans New Look Into Breast Cancer Screening
The U.S. Preventive Services Task Force issued a draft research plan to review the impact of screening with traditional mammography, as well as 3-D imaging, MRI, ultrasound and clinical breast examination on breast-cancer-specific and all-cause mortality, including the benefits of screening starting at age 40. It would be an update to 2009 USPSTF recommendations that were the source of high-profile controversy.
Studies Point To Shortcomings, Some Opportunities In Breast Cancer Screening
Several large studies published last week explore the breast-cancer screening paradigm.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.